Global Stomach Cancer and Gastric Cancer Treatment Market Size, Status and Forecast 2021-2027

胃がん治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Stomach Cancer and Gastric Cancer Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE4024
◆調査・発行会社:QYResearch
◆発行日:2021年6月
◆ページ数:108
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥448,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥672,750見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、胃がん治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(プログラム細胞死タンパク質1(PD-1)阻害剤、ヒト上皮成長因子受容体(HER2)拮抗薬、血管内皮増殖因子受容体(VEGFR)拮抗薬、その他)、用途別市場規模(病院、クリニック)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・胃がん治療の市場動向
・企業の競争状況、市場シェア
・胃がん治療の種類別市場規模(プログラム細胞死タンパク質1(PD-1)阻害剤、ヒト上皮成長因子受容体(HER2)拮抗薬、血管内皮増殖因子受容体(VEGFR)拮抗薬、その他)
・胃がん治療の用途別市場規模(病院、クリニック)
・胃がん治療の北米市場規模2016-2027(アメリカ、カナダ)
・胃がん治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・胃がん治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・胃がん治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・胃がん治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Ipsen Pharma、Merck & Co., Inc.、Bristol-Myers Squibb Company、Eli Lilly、Roche、Novartis AG、Bayer AG、Celltrion Inc.、TAIHO PHARMACEUTICAL CO., LTD.、Jiangsu Hengrui Medicine Co., Ltd.)
・結論

Stomach cancer is the fifth most common cancer in the world

Market Analysis and Insights: Global Stomach Cancer and Gastric Cancer Treatment Market
The global Stomach Cancer and Gastric Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stomach Cancer and Gastric Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stomach Cancer and Gastric Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stomach Cancer and Gastric Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stomach Cancer and Gastric Cancer Treatment market.

Global Stomach Cancer and Gastric Cancer Treatment Scope and Market Size
Stomach Cancer and Gastric Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stomach Cancer and Gastric Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Programmed Cell Death Protein 1 (PD-1) Inhibitors
Human Epidermal Growth Factor Receptor (HER2) Antagonists
Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
Others

Segment by Application
Hospitals
Clinics

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ipsen Pharma
Merck & Co., Inc.
Bristol-Myers Squibb Company
Eli Lilly
Roche
Novartis AG
Bayer AG
Celltrion Inc.
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co., Ltd.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stomach Cancer and Gastric Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Programmed Cell Death Protein 1 (PD-1) Inhibitors
1.2.3 Human Epidermal Growth Factor Receptor (HER2) Antagonists
1.2.4 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
1.2.5 Others
1.3 Market by Application
1.3.1 Global Stomach Cancer and Gastric Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Stomach Cancer and Gastric Cancer Treatment Market Perspective (2016-2027)
2.2 Stomach Cancer and Gastric Cancer Treatment Growth Trends by Regions
2.2.1 Stomach Cancer and Gastric Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stomach Cancer and Gastric Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Stomach Cancer and Gastric Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Stomach Cancer and Gastric Cancer Treatment Industry Dynamic
2.3.1 Stomach Cancer and Gastric Cancer Treatment Market Trends
2.3.2 Stomach Cancer and Gastric Cancer Treatment Market Drivers
2.3.3 Stomach Cancer and Gastric Cancer Treatment Market Challenges
2.3.4 Stomach Cancer and Gastric Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Stomach Cancer and Gastric Cancer Treatment Players by Revenue
3.1.1 Global Top Stomach Cancer and Gastric Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Stomach Cancer and Gastric Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stomach Cancer and Gastric Cancer Treatment Revenue
3.4 Global Stomach Cancer and Gastric Cancer Treatment Market Concentration Ratio
3.4.1 Global Stomach Cancer and Gastric Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stomach Cancer and Gastric Cancer Treatment Revenue in 2020
3.5 Stomach Cancer and Gastric Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Stomach Cancer and Gastric Cancer Treatment Product Solution and Service
3.7 Date of Enter into Stomach Cancer and Gastric Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Stomach Cancer and Gastric Cancer Treatment Breakdown Data by Type
4.1 Global Stomach Cancer and Gastric Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Stomach Cancer and Gastric Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Stomach Cancer and Gastric Cancer Treatment Breakdown Data by Application
5.1 Global Stomach Cancer and Gastric Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Stomach Cancer and Gastric Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Stomach Cancer and Gastric Cancer Treatment Market Size (2016-2027)
6.2 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Type
6.2.1 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Application
6.3.1 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Country
6.4.1 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Stomach Cancer and Gastric Cancer Treatment Market Size (2016-2027)
7.2 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Type
7.2.1 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Application
7.3.1 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Country
7.4.1 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size (2016-2027)
9.2 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Type
9.2.1 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Application
9.3.1 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Country
9.4.1 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ipsen Pharma
11.1.1 Ipsen Pharma Company Details
11.1.2 Ipsen Pharma Business Overview
11.1.3 Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Introduction
11.1.4 Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.1.5 Ipsen Pharma Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Introduction
11.2.4 Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Details
11.3.2 Bristol-Myers Squibb Company Business Overview
11.3.3 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Introduction
11.3.4 Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Stomach Cancer and Gastric Cancer Treatment Introduction
11.4.4 Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Stomach Cancer and Gastric Cancer Treatment Introduction
11.5.4 Roche Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Stomach Cancer and Gastric Cancer Treatment Introduction
11.6.4 Novartis AG Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.6.5 Novartis AG Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Details
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Stomach Cancer and Gastric Cancer Treatment Introduction
11.7.4 Bayer AG Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.7.5 Bayer AG Recent Development
11.8 Celltrion Inc.
11.8.1 Celltrion Inc. Company Details
11.8.2 Celltrion Inc. Business Overview
11.8.3 Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Introduction
11.8.4 Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.8.5 Celltrion Inc. Recent Development
11.9 TAIHO PHARMACEUTICAL CO., LTD.
11.9.1 TAIHO PHARMACEUTICAL CO., LTD. Company Details
11.9.2 TAIHO PHARMACEUTICAL CO., LTD. Business Overview
11.9.3 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Introduction
11.9.4 TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.9.5 TAIHO PHARMACEUTICAL CO., LTD. Recent Development
11.10 Jiangsu Hengrui Medicine Co., Ltd.
11.10.1 Jiangsu Hengrui Medicine Co., Ltd. Company Details
11.10.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
11.10.3 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Introduction
11.10.4 Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
11.10.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Stomach Cancer and Gastric Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Programmed Cell Death Protein 1 (PD-1) Inhibitors
Table 3. Key Players of Human Epidermal Growth Factor Receptor (HER2) Antagonists
Table 4. Key Players of Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
Table 5. Key Players of Others
Table 6. Global Stomach Cancer and Gastric Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Stomach Cancer and Gastric Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Stomach Cancer and Gastric Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Stomach Cancer and Gastric Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Stomach Cancer and Gastric Cancer Treatment Market Trends
Table 13. Stomach Cancer and Gastric Cancer Treatment Market Drivers
Table 14. Stomach Cancer and Gastric Cancer Treatment Market Challenges
Table 15. Stomach Cancer and Gastric Cancer Treatment Market Restraints
Table 16. Global Stomach Cancer and Gastric Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Stomach Cancer and Gastric Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer and Gastric Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Stomach Cancer and Gastric Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Stomach Cancer and Gastric Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Stomach Cancer and Gastric Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Stomach Cancer and Gastric Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Stomach Cancer and Gastric Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Stomach Cancer and Gastric Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Stomach Cancer and Gastric Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Ipsen Pharma Company Details
Table 64. Ipsen Pharma Business Overview
Table 65. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Product
Table 66. Ipsen Pharma Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. Ipsen Pharma Recent Development
Table 68. Merck & Co., Inc. Company Details
Table 69. Merck & Co., Inc. Business Overview
Table 70. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Product
Table 71. Merck & Co., Inc. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Merck & Co., Inc. Recent Development
Table 73. Bristol-Myers Squibb Company Company Details
Table 74. Bristol-Myers Squibb Company Business Overview
Table 75. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Product
Table 76. Bristol-Myers Squibb Company Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Company Recent Development
Table 78. Eli Lilly Company Details
Table 79. Eli Lilly Business Overview
Table 80. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Product
Table 81. Eli Lilly Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. Eli Lilly Recent Development
Table 83. Roche Company Details
Table 84. Roche Business Overview
Table 85. Roche Stomach Cancer and Gastric Cancer Treatment Product
Table 86. Roche Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Novartis AG Company Details
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Stomach Cancer and Gastric Cancer Treatment Product
Table 91. Novartis AG Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 92. Novartis AG Recent Development
Table 93. Bayer AG Company Details
Table 94. Bayer AG Business Overview
Table 95. Bayer AG Stomach Cancer and Gastric Cancer Treatment Product
Table 96. Bayer AG Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 97. Bayer AG Recent Development
Table 98. Celltrion Inc. Company Details
Table 99. Celltrion Inc. Business Overview
Table 100. Celltrion Inc. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 101. Celltrion Inc. Recent Development
Table 102. TAIHO PHARMACEUTICAL CO., LTD. Company Details
Table 103. TAIHO PHARMACEUTICAL CO., LTD. Business Overview
Table 104. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Product
Table 105. TAIHO PHARMACEUTICAL CO., LTD. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 106. TAIHO PHARMACEUTICAL CO., LTD. Recent Development
Table 107. Jiangsu Hengrui Medicine Co., Ltd. Company Details
Table 108. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 109. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Product
Table 110. Jiangsu Hengrui Medicine Co., Ltd. Revenue in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021) & (US$ Million)
Table 111. Jiangsu Hengrui Medicine Co., Ltd. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Programmed Cell Death Protein 1 (PD-1) Inhibitors Features
Figure 3. Human Epidermal Growth Factor Receptor (HER2) Antagonists Features
Figure 4. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Features
Figure 5. Others Features
Figure 6. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Stomach Cancer and Gastric Cancer Treatment Report Years Considered
Figure 10. Global Stomach Cancer and Gastric Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Stomach Cancer and Gastric Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Regions (2022-2027)
Figure 14. Global Stomach Cancer and Gastric Cancer Treatment Market Share by Players in 2020
Figure 15. Global Top Stomach Cancer and Gastric Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stomach Cancer and Gastric Cancer Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Stomach Cancer and Gastric Cancer Treatment Revenue in 2020
Figure 17. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Stomach Cancer and Gastric Cancer Treatment Market Share by Type (2016-2027)
Figure 21. North America Stomach Cancer and Gastric Cancer Treatment Market Share by Application (2016-2027)
Figure 22. North America Stomach Cancer and Gastric Cancer Treatment Market Share by Country (2016-2027)
Figure 23. United States Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Stomach Cancer and Gastric Cancer Treatment Market Share by Type (2016-2027)
Figure 27. Europe Stomach Cancer and Gastric Cancer Treatment Market Share by Application (2016-2027)
Figure 28. Europe Stomach Cancer and Gastric Cancer Treatment Market Share by Country (2016-2027)
Figure 29. Germany Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Market Share by Region (2016-2027)
Figure 39. China Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Stomach Cancer and Gastric Cancer Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Stomach Cancer and Gastric Cancer Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Stomach Cancer and Gastric Cancer Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Stomach Cancer and Gastric Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Ipsen Pharma Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 59. Merck & Co., Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 65. Celltrion Inc. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 66. TAIHO PHARMACEUTICAL CO., LTD. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 67. Jiangsu Hengrui Medicine Co., Ltd. Revenue Growth Rate in Stomach Cancer and Gastric Cancer Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[胃がん治療の世界市場規模・現状・予測2021年-2027年] (Global Stomach Cancer and Gastric Cancer Treatment Market Size, Status and Forecast 2021-2027 / QY21JNE4024)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆